Literature DB >> 20484670

Soluble forms of VEGF receptor-1 and -2 promote vascular maturation via mural cell recruitment.

Sophie Lorquet1, Sarah Berndt, Silvia Blacher, Emily Gengoux, Olivier Peulen, Erik Maquoi, Agnès Noël, Jean-Michel Foidart, Carine Munaut, Christel Péqueux.   

Abstract

Two soluble forms of vascular endothelial growth factor (VEGF) receptors, sVEGFR-1 and sVEGFR-2, are physiologically released and overproduced in some pathologies. They are known to act as anti-VEGF agents. Here we report that these soluble receptors contribute to vessel maturation by mediating a dialogue between endothelial cells (ECs) and mural cells that leads to blood vessel stabilization. Through a multidisciplinary approach, we provide evidence that these soluble VEGF receptors promote mural cell migration through a paracrine mechanism involving interplay in ECs between VEGF/VEGFR-2 and sphingosine-1-phosphate type-1 (S1P)/S1P1 pathways that leads to endothelial nitric oxyde synthase (eNOS) activation. This new paradigm is supported by the finding that sVEGFR-1 and -2 perform the following actions: 1) induce an eNOS-dependent outgrowth of a mural cell network in an ex vivo model of angiogenesis, 2) increase the mural cell coverage of neovessels in vitro and in vivo, 3) promote mural cell migration toward ECs, and 4) stimulate endothelial S1P1 overproduction and eNOS activation that promote the migration and the recruitment of neighboring mural cells. These findings provide new insights into mechanisms regulating physiological and pathological angiogenesis and vessel stabilization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20484670     DOI: 10.1096/fj.09-149070

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  14 in total

1.  Soluble VEGF receptor 1 promotes endothelial injury in children and adolescents with lupus nephritis.

Authors:  Monika Edelbauer; Sudhir Kshirsagar; Magdalena Riedl; Heiko Billing; Burkhard Tönshoff; Dieter Haffner; Jörg Dötsch; Gottfried Wechselberger; Lutz T Weber; Elisabeth Steichen-Gersdorf
Journal:  Pediatr Nephrol       Date:  2011-12-07       Impact factor: 3.714

2.  Hypoxia-regulated overexpression of soluble VEGFR2 controls angiogenesis and inhibits tumor growth.

Authors:  Guillaume Collet; Nathalie Lamerant-Fayel; Magdalena Tertil; Bouchra El Hafny-Rahbi; Jacek Stepniewski; Alan Guichard; Alexandra Foucault-Collet; Krzysztof Klimkiewicz; Stéphane Petoud; Agata Matejuk; Catherine Grillon; Alicja Jozkowicz; Jozef Dulak; Claudine Kieda
Journal:  Mol Cancer Ther       Date:  2013-10-29       Impact factor: 6.261

Review 3.  Targeting microvasculature for neuroprotection after SCI.

Authors:  Janelle M Fassbender; Scott R Whittemore; Theo Hagg
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

4.  Altered expression of endogenous soluble vascular endothelial growth factor receptor-2 is involved in the progression of esophageal squamous cell carcinoma.

Authors:  Zhi-Yong Wu; Tao Chen; Qing Zhao; Jian-Hao Huang; Jie-Xin Chen; Chun-Peng Zheng; Xiu-E Xu; Jian-Yi Wu; Li-Yan Xu; En-Min Li
Journal:  J Histochem Cytochem       Date:  2013-02-07       Impact factor: 2.479

5.  Soluble VEGFR1 concentration in the serum of patients with colorectal cancer.

Authors:  Oranus Abbasi; Farhad Mashayekhi; Ebrahim Mirzajani; Saba Fakhriyeh Asl; Touraj Mahmoudi; Hamid Saeedi Saedi
Journal:  Surg Today       Date:  2014-03-28       Impact factor: 2.549

Review 6.  Angiogenic factors and inflammation in steroid-refractory acute graft-vs-host disease.

Authors:  Shernan G Holtan; Mukta Arora
Journal:  Transl Res       Date:  2015-06-09       Impact factor: 7.012

Review 7.  Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system.

Authors:  Mirjam Schuchardt; Markus Tölle; Jasmin Prüfer; Markus van der Giet
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

8.  Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications.

Authors:  Xiujun Fan; Anshita Rai; Neeraja Kambham; Joyce F Sung; Nirbhai Singh; Matthew Petitt; Sabita Dhal; Rani Agrawal; Richard E Sutton; Maurice L Druzin; Sanjiv S Gambhir; Balamurali K Ambati; James C Cross; Nihar R Nayak
Journal:  J Clin Invest       Date:  2014-10-20       Impact factor: 14.808

9.  Characterizing the angiogenic activity of patients with single ventricle physiology and aortopulmonary collateral vessels.

Authors:  Nefthi Sandeep; Yutaka Uchida; Kanishka Ratnayaka; Robert McCarter; Sridhar Hanumanthaiah; Aminata Bangoura; Zhen Zhao; Jacqueline Oliver-Danna; Linda Leatherbury; Joshua Kanter; Yoh-Suke Mukouyama
Journal:  J Thorac Cardiovasc Surg       Date:  2015-10-09       Impact factor: 5.209

10.  Paracrine factors secreted by umbilical cord-derived mesenchymal stem cells induce angiogenesis in vitro by a VEGF-independent pathway.

Authors:  Pushpa Kuchroo; Viral Dave; Ajay Vijayan; Chandra Viswanathan; Deepa Ghosh
Journal:  Stem Cells Dev       Date:  2014-11-03       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.